RT @MSKHemOncTrials: Chemo-refractory DLBCL & indolent B-cell malignancies effectively treated with CD19 CAR T cells #MSKCART17 https://t.…
19,708 followers
1,699 followers
Chemo-refractory DLBCL & indolent B-cell malignancies effectively treated with CD19 CAR T cells #MSKCART17 https://t.co/YVPmTnZY58
26 followers
@Wresssel @PaulinaMagdale @TVVde @julemarie27 @PETADeutschland Ein Beispiel "CAR": Tierversuche https://t.co/cZ5vLe714U führten zur Klinik https://t.co/ObvG1Y0CaU und dann zur FDA https://t.co/lRrLAlibTu
5,920 followers
@biotechbug @w_biltmore85 @JacobPlieth Expectation was close to 50% CR, based on first academic paper https://t.co/rVphIUC0tc